Skip Navigation
Skip to contents
Search
Home
Current
Current issue
Ahead-of print
Browse
All issues
Article by category
Article by topic
Article by Category
2022-2023
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
Collections
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
For contributors
For Authors
Instructions to authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
About
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
Editorial policy
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
E-Submission
KDA
Contact us
E-SUBMISSION
mobile menu button
Current
Current issue
Ahead-of print
Browse
All issues
Article by category
Article by topic
Article by Category
2022-2023
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
Collections
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
For contributors
For Authors
Instructions to authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
About
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
Editorial policy
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
Articles
Page Path
HOME
>
Diabetes Metab J
>
Volume 32(6); 2008
> Article
Letter
The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.
Dong Lim Kim
Diabetes & Metabolism Journal 2008;32(6):532-533
DOI:
https://doi.org/10.4093/kdj.2008.32.6.532
Published online: December 1, 2008
1,972
Views
17
Download
0
Crossref
0
Scopus
Author Affiliations
Article notes
Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University School of Medicine, Korea.
Full Article
Full Article
Figure & data
Reference
Citations
Metrics
Download PDF
Twitter
Facebook
Linked
Email
Abstract
No abstract available.
Figure & Data
References
Citations
Citations to this article as recorded by
Cite
CITE
export
Copy
Format
NLM
AMA
APA
MLA
Close
Download Citation
Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
Format:
RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
Include:
Citation for the content below
Citation and abstract for the content below
The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.
Korean Diabetes J.
2008;32(6):532-533. Published online December 1, 2008
DOI:
https://doi.org/10.4093/kdj.2008.32.6.532
Close
Related articles
Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus
Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus
Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus
Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease